
Sign up to save your podcasts
Or
This week, I speak with Blaise Nemeth, a pediatric orthopedist affiliated with the University of Wisconsin in Madison. He is one of the few non-operative pediatric orthopedists in the United States also known as NoPos.
We talk about the pathway to becoming a non-operative pediatric orthopedist and the value they can bring to benefit patients as well as his career path
We discuss practical issues, including the financial aspects of incorporating non-operative orthopedists and advanced practice providers.
He explained his approach to diagnosing and managing hip dysplasia in infants and how to integrate other specialties when dealing with complex patients.
We examine the bias in most literature regarding Legg Calvé Perthes, where surgeons have typically run research, which creates a bias towards surgical treatment.
We discussed slipped capital femoral epiphysis and speculated on the rapid rise in popularity of GLP-1agonists for weight loss and their implications for musculoskeletal medicine, specifically pediatric orthopedic conditions. We also talked about the support structure and networks available to non-operative orthopedists.
This week, I speak with Blaise Nemeth, a pediatric orthopedist affiliated with the University of Wisconsin in Madison. He is one of the few non-operative pediatric orthopedists in the United States also known as NoPos.
We talk about the pathway to becoming a non-operative pediatric orthopedist and the value they can bring to benefit patients as well as his career path
We discuss practical issues, including the financial aspects of incorporating non-operative orthopedists and advanced practice providers.
He explained his approach to diagnosing and managing hip dysplasia in infants and how to integrate other specialties when dealing with complex patients.
We examine the bias in most literature regarding Legg Calvé Perthes, where surgeons have typically run research, which creates a bias towards surgical treatment.
We discussed slipped capital femoral epiphysis and speculated on the rapid rise in popularity of GLP-1agonists for weight loss and their implications for musculoskeletal medicine, specifically pediatric orthopedic conditions. We also talked about the support structure and networks available to non-operative orthopedists.